Elysse Dean
St Leonards, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devices.
Journal: Clinical chemistry and laboratory medicine
Published: March 16, 2026
Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment Programmes.
Journal: International journal of laboratory hematology
Published: July 02, 2025
Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.
Journal: International journal of laboratory hematology
Published: October 02, 2024
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers-for the External Quality Assurance in Thrombosis and Haemostasis Group.
Journal: Seminars in thrombosis and hemostasis
Published: August 16, 2024
Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific Experience.
Journal: Seminars in thrombosis and hemostasis
Published: March 01, 2024
Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia-Pacific experience.
Journal: International journal of laboratory hematology
Published: February 04, 2024
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience.
Journal: Seminars in thrombosis and hemostasis
Published: November 15, 2023
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience.
Journal: Seminars in thrombosis and hemostasis
Published: July 08, 2022
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference.
Journal: Clinical chemistry and laboratory medicine
Published: November 10, 2019
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 07, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026